(Q44135936)

30 November 2017

title

Inhibition of human MDA-MB-231 breast cancer cell invasion by matrix metalloproteinase 3 involves degradation of plasminogen (English)

1 reference

30 November 2017

5

1 reference

30 November 2017

Antonietta R Farina

1

1 reference

30 November 2017

Antonella Tacconelli

series ordinal

2

1 reference

30 November 2017

Lucia Cappabianca

series ordinal

3

1 reference

30 November 2017

Alberto Gulino

series ordinal

4

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

269

1 reference

30 November 2017

issue

18

1 reference

30 November 2017

page(s)

4476-4483

1 reference

Myoepithelial and basement membrane antigens in benign and malignant human breast tumors

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

The basement-membrane-like matrix of the mouse EHS tumor: II. Immunohistochemical quantitation of six of its components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

Basement membrane complexes with biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

Transforming growth factor-beta1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

Biology and biochemistry of proteinases in tumor invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

The plasminogen activation system in tumor growth, invasion, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

Retinoic acid-enhanced invasion through reconstituted basement membrane by human SK-N-SH neuroblastoma cells involves membrane-associated tissue-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

Changing views of the role of matrix metalloproteinases in metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

Matrix metalloproteinases and cellular fibrinolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

Kringle domains and plasmin denaturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

Increased plasminogen binding is associated with metastatic breast cancer cells: differential expression of plasminogen binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

On the specific interaction between the lysine-binding sites in plasmin and complementary sites in α2-antiplasmin and in fibrinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03142.X

10.1046/J.1432-1033.2002.03142.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference